Thyrocare Technologies Bonus Issue: Record Date Tomorrow (Nov 28) for 2:1 Allotment

Thyrocare Technologies Limited has announced that Friday, November 28, 2025, will be the record date to determine shareholder eligibility for its 2:1 bonus issue. 

Investors must hold shares as of tomorrow to receive two bonus equity shares for every one fully paid-up equity share they own. The bonus issue received board approval earlier and was cleared by shareholders on November 16, 2025.

Details of the 2:1 Bonus Share Allotment

Under the approved ratio, shareholders will receive two bonus equity shares of face value ₹10 each for every existing share. In line with SEBI’s updated framework, the deemed date of allotment is Monday, December 1, 2025. The bonus shares will be credited to demat accounts and made available for trading beginning Tuesday, December 2, 2025.

Compliance with SEBI’s Updated Process

As mandated under SEBI circular CIR/CFD/PoD/2024/122, Thyrocare has aligned the bonus issue timeline with regulatory requirements to ensure transparency and faster processing. The record date scheduled for tomorrow finalises the eligible shareholder list and ensures a smooth corporate action execution.

Other Recent Corporate Actions

The company recently declared an interim dividend of ₹7 per share with a record date of October 24, 2025, and a final dividend of ₹21 per share with a record date of July 25, 2025.

Also Read: Upcoming NFO: Jio BlackRock Filed SID with SEBI for JioBlackRock Sector Rotation Fund!

Conclusion

Since the record date falls tomorrow, investors holding Thyrocare shares by the end of today will qualify for the 2:1 bonus issue. Bonus shares will be allotted on December 1 and begin trading on December 2, 2025, enhancing liquidity and widening investor participation.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a private recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.